Molecular therapy oncolytics.

" ... fields of oncolytic virotherapy and T cell-based therapies, Molecular Therapy-- Oncolytics considers top-quality, cutting-edge research that employs innovative molecular and cellular approaches that target cancer cells for destruction, whether by viruses, other microorganisms, vaccination...

Full description

Saved in:
Bibliographic Details
Place / Publishing House:New York, NY : : Nature Publishing Group,, [2014]-[2023]
Cambridge : : Cell Press
Publication history:Began with: 1 article number 14004 (2014); ceased with Volume 31 (December 2023).
Language:English
Physical Description:1 online resource
Notes:Refereed/Peer-reviewed
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 00000nas-a2200673-i-4500
001 993575546504498
005 20240129213017.0
006 m-----o--d--------
007 cr-|||||||||||
008 140505d20142023mau-x-p-o-----0---a0eng--
010 |a  2014201829 
016 7 |a 101666776  |2 DNLM 
035 |a (DE-599)ZDB2842549-2 
035 |a (OCoLC)879171460 
035 |a (CKB)2670000000556853 
035 |a (CONSER)--2014201829 
035 |a (EXLCZ)992670000000556853 
037 |b Nature Publishing Group, 75 Varick Street, 9th Floor, New York, NY 10013 
042 |a pcc  |a nsdp 
050 0 0 |a RC271.C44 
060 0 0 |a W1 
082 0 0 |a 616.99406  |2 23 
210 |a MOL THER ONCOLYTICS 
210 1 0 |a Mol Ther Oncolytics  |2 dnlm 
210 0 |a Mol. ther. oncolytics 
222 0 |a Molecular therapy oncolytics 
245 0 0 |a Molecular therapy oncolytics. 
246 1 |a MTO 
264 1 |a New York, NY :  |b Nature Publishing Group,  |c [2014]-[2023] 
264 3 1 |3 <2017?->  |a Cambridge :  |b Cell Press 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
362 1 |a Began with: 1 article number 14004 (2014); ceased with Volume 31 (December 2023). 
500 |a Refereed/Peer-reviewed 
506 0 |f Unrestricted online access  |2 star 
515 |a Articles added as received to annual volume in progress. 
520 |a " ... fields of oncolytic virotherapy and T cell-based therapies, Molecular Therapy-- Oncolytics considers top-quality, cutting-edge research that employs innovative molecular and cellular approaches that target cancer cells for destruction, whether by viruses, other microorganisms, vaccination, or by transfer of cells and/or genes." 
588 |a Description based on: 1, article number 14004 (2014); title from PDF header (publisher's Web site, viewed Sept. 11, 2015). 
588 |a Latest issue consulted: Volume 11 (2018) (Cell Press web site, viewed November 26, 2018). 
650 0 |a Cancer  |x Treatment  |v Periodicals. 
650 0 |a Viruses  |x Therapeutic use  |v Periodicals. 
650 0 |a Cellular therapy  |v Periodicals. 
650 1 2 |a Neoplasms. 
650 2 2 |a Genetic Therapy. 
650 2 2 |a Molecular Biology. 
650 7 |a Cancer  |x Treatment.  |2 fast  |0 (OCoLC)fst00845538 
650 7 |a Cellular therapy.  |2 fast  |0 (OCoLC)fst00850322 
650 7 |a Viruses  |x Therapeutic use.  |2 fast  |0 (OCoLC)fst01167787 
653 |a Oncology 
655 2 |a Periodical. 
655 4 |a Fulltext. 
655 4 |a Internet Resources. 
655 4 |a Periodicals. 
655 7 |a Periodicals.  |2 fast  |0 (OCoLC)fst01411641 
776 |x 2372-7705 
906 |a JOURNAL 
ADM |b 2024-03-13 11:04:05 Europe/Vienna  |f system  |c marc21  |a 2014-05-03 20:46:25 Europe/Vienna  |g false 
AVE |i DOAJ Directory of Open Access Journals  |P DOAJ Directory of Open Access Journals  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5342233910004498&Force_direct=true  |Z 5342233910004498  |m  Available from 2014.  |b Available  |8 5342233910004498 
AVE |Z 5342233910004498  |A 2014